Perspectives and insights regarding regulatory considerations when planning and conducting immunotherapy studies.
Anna Baran, MD
Advertisement
Articles by Anna Baran, MD
Applied Clinical Trials
IMPs for immunotherapeutics require a different mindset, effective strategies, and meticulous planning, among other things, says KCR Trial Execution and Consulting.
Advertisement
Latest Updated Articles
- Initial Design Considerations for Immuno-Oncology Trials
August 13th 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials at the 2026 DIA Global Annual Meeting: Conversations on Data, Outsourcing, and the Patient Voice
2
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
3
ACT Brief: Bridging Site-Sponsor Data Gaps, Major Study Retraction, and TNBC First-Line Approval
4
ACT Brief: DIA Leadership Amid Uncertainty, Reimagining CRO Contracts, and Eli Lilly Expansion
5